Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji

被引:13
作者
Wilson, N
Mansoor, O
Wenger, J
Martin, R
Zanardi, L
O'Leary, M
Rabukawaqa, V
机构
[1] Karori, Wellington, New Zealand
[2] WHO, Manila, Philippines
[3] WHO, CH-1211 Geneva, Switzerland
[4] Ctr Dis Control & Prevent, Atlanta, GA USA
[5] WHO, Suva, Fiji
[6] Minist Hlth, Suva, Fiji
关键词
Haemophilus influenzae; rapid assessment tool; Pacific;
D O I
10.1016/S0264-410X(02)00825-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aims: To estimate Haemophilus influenzae type b (Hib) disease burden in Fiji in children under the age of 5 years (under-5s) prior to vaccine introduction. To compare estimates from WHO's Hib rapid assessment tool (RAT), with that from decline in disease after vaccine introduction. Methods: Laboratory data (meningitis), hospitalization and mortality data (pneumonia and meningitis) before and after Hib vaccine introduction were collected. The RAT protocol provides two independent estimates of pre-vaccine disease burden (one based on meningitis incidence laboratory data and the other based on mortality statistics). A third estimate uses the decline in disease following vaccine introduction. Results: The decline in meningitis hospitalizations implies a pre-vaccine Hib meningitis incidence of 66 per 100,000 in under-5s. This compares with a pre-vaccine RAT estimate of Hib meningitis incidence of 84 per 100,000 (for 1992-1993). The RAT estimated the total annual pre-vaccine Hib burden (meningitis plus pneumonia) at 476 cases and 36 deaths per year ("meningitis incidence method") and 70 cases and 5 deaths ("child mortality method"). Hib vaccine led to declines of 32% (95% confidence interval (CI) = 11-48%), and 78% (95% CI = 22-94%) for all under-5s meningitis hospitalizations and deaths, respectively. There was no similar consistent decline in pneumonia hospitalizations or deaths after vaccine introduction, except for a statistically significant reduction in pneumonia mortality in children aged under 1 year. Conclusions: Hib disease constitutes an important burden on the health of Pacific children that can be rapidly reduced with Hib vaccine. In this setting, routine morbidity statistics (comparing pre-and post-vaccine) provided an estimate of Hib meningitis burden which is broadly similar to that of the Hib RAT, suggesting that both might be valid ways to estimate Hib meningitis incidence. However, Hib pneumonia burden could not be estimated from routine statistics. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1907 / 1912
页数:6
相关论文
共 13 条
[1]  
Adams T, 2000, B WORLD HEALTH ORGAN, V78, P1375
[2]   INVASIVE HAEMOPHILUS-INFLUENZAE DISEASE OF MELANESIAN AND CAUCASIAN CHILDREN IN NEW-CALEDONIA [J].
ANGLARET, X ;
BUISSONNIERE, RF ;
DUVAL, P ;
MORLAT, C ;
MENAGER, C .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (10) :888-889
[3]  
[Anonymous], 1998, WKLY EPIDEMIOL REC, V73, P64
[4]  
CARROLL K, 1993, PAPUA NEW GUINEA MED, V36, P234
[5]  
DEAN AG, 1996, EPI INFO VERSION 6 0
[6]   Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: Practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections [J].
Lagos, R ;
Horwitz, I ;
Toro, J ;
Martin, OS ;
Abrego, P ;
Bustamante, C ;
Wasserman, SS ;
Levine, OS ;
Levine, MM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) :216-222
[7]   Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants [J].
Mulholland, K ;
Hilton, S ;
Adegbola, R ;
Usen, S ;
Oparaugo, A ;
Omosigho, C ;
Weber, M ;
Palmer, A ;
Schneider, G ;
Jobe, K ;
Lahai, G ;
Jaffar, S ;
Secka, O ;
Lin, K ;
Ethevenaux, C ;
Greenwood, B .
LANCET, 1997, 349 (9060) :1191-1197
[8]   Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century:: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates [J].
Peltola, H .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (02) :302-+
[9]  
*WHO, 2000, WHOVB0125
[10]  
WHO, 1998, DEM DAT HLTH SIT ASS